Jordi Alonso1,2,3, Zhaorui Liu4, Sara Evans-Lacko5,6, Ekaterina Sadikova7, Nancy Sampson7, Somnath Chatterji8, Jibril Abdulmalik9, Sergio Aguilar-Gaxiola10, Ali Al-Hamzawi11, Laura H Andrade12, Ronny Bruffaerts13, Graça Cardoso14, Alfredo Cia15, Silvia Florescu16, Giovanni de Girolamo17, Oye Gureje9, Josep M Haro18, Yanling He19, Peter de Jonge20,21, Elie G Karam22,23, Norito Kawakami24, Viviane Kovess-Masfety25, Sing Lee26, Daphna Levinson27, Maria Elena Medina-Mora28, Fernando Navarro-Mateu29, Beth-Ellen Pennell30, Marina Piazza31,32, José Posada-Villa33, Margreet Ten Have34, Zahari Zarkov35, Ronald C Kessler7, Graham Thornicroft5. 1. Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain. 2. Pompeu Fabra University (UPF), Barcelona, Spain. 3. CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain. 4. Institute of Mental Health, Peking University, Beijing, China. 5. Institute of Psychiatry, Psychology & Neuroscience, Kings College London, London, United Kingdom. 6. PSSRU, London School of Economics and Political Science, London, United Kingdom. 7. Department of Health Care Policy, Harvard Medical School, Boston, MA, USA. 8. Department of Information, Evidence and Research, World Health Organization, Geneva, Switzerland. 9. Department of Psychiatry, University College Hospital, Ibadan, Nigeria. 10. Center for Reducing Health Disparities, UC Davis Health System, Sacramento, CA, USA. 11. College of Medicine, Al-Qadisiya University, Diwaniya governorate, Iraq. 12. Núcleo de Epidemiologia Psiquiátrica - LIM 23, Instituto de Psiquiatria Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Brazil. 13. Universitair Psychiatrisch Centrum-Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium. 14. Department of Mental Health, Faculdades de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal. 15. Anxiety Disorders Center, Buenos Aires, Argentina. 16. National School of Public Health, Management and Development, Bucharest, Romania. 17. Unit of Epidemiological and Evaluation Psychiatry, IRCCS-St. John of God Clinical Research Centre, Brescia, Italy. 18. Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Sant Boi de Llobregat, Barcelona, Spain. 19. Shanghai Mental Health Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. 20. Developmental Psychology, Department of Psychology, Rijksuniversiteit Groningen, Groningen, Netherlands. 21. Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion Regulation, University Medical Center Groningen, Groningen, Netherlands. 22. Department of Psychiatry and Clinical Psychology, Faculty of Medicine, St George Hospital University Medical Center, Balamand University, Beirut, Lebanon. 23. Institute for Development, Research, Advocacy and Applied Care (IDRAAC), Beirut, Lebanon. 24. Department of Mental Health, School of Public Health, The University of Tokyo, Tokyo, Japan. 25. Ecole des Hautes Etudes en Santé Publique (EHESP), EA 4057, Paris Descartes University, Paris, France. 26. Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong. 27. Mental Health Services, Ministry of Health, Jerusalem, Israel. 28. National Institute of Psychiatry Ramón de la Fuente, Mexico City, Mexico. 29. UDIF-SM, Subdirección General de Planificación, Innovación y Cronicidad, Servicio Murciano de Salud. IMIB-Arrixaca, Murcia, Spain, CIBERESP-Murcia, Murcia, Spain. 30. Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA. 31. Universidad Cayetano Heredia, Lima, Peru. 32. National Institute of Health, Lima, Peru. 33. Faculty of Social Sciences, Colegio Mayor de Cundinamarca University, Bogota, Colombia. 34. Trimbos-Instituut, Netherlands Institute of Mental Health and Addiction, Utrecht, Netherlands. 35. Directorate of Mental Health, National Center of Public Health and Analyses, Sofia, Bulgaria.
Abstract
BACKGROUND: Anxiety disorders are a major cause of burden of disease. Treatment gaps have been described, but a worldwide evaluation is lacking. We estimated, among individuals with a 12-month DSM-IV (where DSM is Diagnostic Statistical Manual) anxiety disorder in 21 countries, the proportion who (i) perceived a need for treatment; (ii) received any treatment; and (iii) received possibly adequate treatment. METHODS: Data from 23 community surveys in 21 countries of the World Mental Health (WMH) surveys. DSM-IV mental disorders were assessed (WHO Composite International Diagnostic Interview, CIDI 3.0). DSM-IV included posttraumatic stress disorder among anxiety disorders, while it is not considered so in the DSM-5. We asked if, in the previous 12 months, respondents felt they needed professional treatment and if they obtained professional treatment (specialized/general medical, complementary alternative medical, or nonmedical professional) for "problems with emotions, nerves, mental health, or use of alcohol or drugs." Possibly adequate treatment was defined as receiving pharmacotherapy (1+ months of medication and 4+ visits to a medical doctor) or psychotherapy, complementary alternative medicine or nonmedical care (8+ visits). RESULTS: Of 51,547 respondents (response = 71.3%), 9.8% had a 12-month DSM-IV anxiety disorder, 27.6% of whom received any treatment, and only 9.8% received possibly adequate treatment. Of those with 12-month anxiety only 41.3% perceived a need for care. Lower treatment levels were found for lower income countries. CONCLUSIONS: Low levels of service use and a high proportion of those receiving services not meeting adequacy standards for anxiety disorders exist worldwide. Results suggest the need for improving recognition of anxiety disorders and the quality of treatment.
BACKGROUND:Anxiety disorders are a major cause of burden of disease. Treatment gaps have been described, but a worldwide evaluation is lacking. We estimated, among individuals with a 12-month DSM-IV (where DSM is Diagnostic Statistical Manual) anxiety disorder in 21 countries, the proportion who (i) perceived a need for treatment; (ii) received any treatment; and (iii) received possibly adequate treatment. METHODS: Data from 23 community surveys in 21 countries of the World Mental Health (WMH) surveys. DSM-IV mental disorders were assessed (WHO Composite International Diagnostic Interview, CIDI 3.0). DSM-IV included posttraumatic stress disorder among anxiety disorders, while it is not considered so in the DSM-5. We asked if, in the previous 12 months, respondents felt they needed professional treatment and if they obtained professional treatment (specialized/general medical, complementary alternative medical, or nonmedical professional) for "problems with emotions, nerves, mental health, or use of alcohol or drugs." Possibly adequate treatment was defined as receiving pharmacotherapy (1+ months of medication and 4+ visits to a medical doctor) or psychotherapy, complementary alternative medicine or nonmedical care (8+ visits). RESULTS: Of 51,547 respondents (response = 71.3%), 9.8% had a 12-month DSM-IV anxiety disorder, 27.6% of whom received any treatment, and only 9.8% received possibly adequate treatment. Of those with 12-month anxiety only 41.3% perceived a need for care. Lower treatment levels were found for lower income countries. CONCLUSIONS: Low levels of service use and a high proportion of those receiving services not meeting adequacy standards for anxiety disorders exist worldwide. Results suggest the need for improving recognition of anxiety disorders and the quality of treatment.
Authors: Elena Olariu; Carlos G Forero; Jose Ignacio Castro-Rodriguez; Maria Teresa Rodrigo-Calvo; Pilar Álvarez; Luis M Martín-López; Alicia Sánchez-Toto; Núria D Adroher; Maria J Blasco-Cubedo; Gemma Vilagut; Miquel A Fullana; Jordi Alonso Journal: Depress Anxiety Date: 2015-03-31 Impact factor: 6.505
Authors: Josep Maria Haro; Saena Arbabzadeh-Bouchez; Traolach S Brugha; Giovanni de Girolamo; Margaret E Guyer; Robert Jin; Jean Pierre Lepine; Fausto Mazzi; Blanca Reneses; Gemma Vilagut; Nancy A Sampson; Ronald C Kessler Journal: Int J Methods Psychiatr Res Date: 2006 Impact factor: 4.035
Authors: Philip S Wang; Sergio Aguilar-Gaxiola; Jordi Alonso; Matthias C Angermeyer; Guilherme Borges; Evelyn J Bromet; Ronny Bruffaerts; Giovanni de Girolamo; Ron de Graaf; Oye Gureje; Josep Maria Haro; Elie G Karam; Ronald C Kessler; Viviane Kovess; Michael C Lane; Sing Lee; Daphna Levinson; Yutaka Ono; Maria Petukhova; José Posada-Villa; Soraya Seedat; J Elisabeth Wells Journal: Lancet Date: 2007-09-08 Impact factor: 79.321
Authors: Koen Demyttenaere; Ronny Bruffaerts; Jose Posada-Villa; Isabelle Gasquet; Viviane Kovess; Jean Pierre Lepine; Matthias C Angermeyer; Sebastian Bernert; Giovanni de Girolamo; Pierluigi Morosini; Gabriella Polidori; Takehiko Kikkawa; Norito Kawakami; Yutaka Ono; Tadashi Takeshima; Hidenori Uda; Elie G Karam; John A Fayyad; Aimee N Karam; Zeina N Mneimneh; Maria Elena Medina-Mora; Guilherme Borges; Carmen Lara; Ron de Graaf; Johan Ormel; Oye Gureje; Yucun Shen; Yueqin Huang; Mingyuan Zhang; Jordi Alonso; Josep Maria Haro; Gemma Vilagut; Evelyn J Bromet; Semyon Gluzman; Charles Webb; Ronald C Kessler; Kathleen R Merikangas; James C Anthony; Michael R Von Korff; Philip S Wang; Traolach S Brugha; Sergio Aguilar-Gaxiola; Sing Lee; Steven Heeringa; Beth-Ellen Pennell; Alan M Zaslavsky; T Bedirhan Ustun; Somnath Chatterji Journal: JAMA Date: 2004-06-02 Impact factor: 56.272
Authors: Meredith G Harris; Chrianna Bharat; Meyer D Glantz; Nancy A Sampson; Ali Al-Hamzawi; Jordi Alonso; Ronny Bruffaerts; José Miguel Caldas de Almeida; Alfredo H Cia; Giovanni de Girolamo; Silvia Florescu; Oye Gureje; Josep Maria Haro; Hristo Hinkov; Elie G Karam; Georges Karam; Sing Lee; Jean-Pierre Lépine; Daphna Levinson; Victor Makanjuola; John McGrath; Zeina Mneimneh; Fernando Navarro-Mateu; Marina Piazza; José Posada-Villa; Charlene Rapsey; Hisateru Tachimori; Margreet Ten Have; Yolanda Torres; Maria Carmen Viana; Somnath Chatterji; Alan M Zaslavsky; Ronald C Kessler; Louisa Degenhardt Journal: Addiction Date: 2019-06-02 Impact factor: 6.526
Authors: Daniel Fernández; Daniel Vigo; Nancy A Sampson; Irving Hwang; Sergio Aguilar-Gaxiola; Ali O Al-Hamzawi; Jordi Alonso; Laura Helena Andrade; Evelyn J Bromet; Giovanni de Girolamo; Peter de Jonge; Silvia Florescu; Oye Gureje; Hristo Hinkov; Chiyi Hu; Elie G Karam; Georges Karam; Norito Kawakami; Andrzej Kiejna; Viviane Kovess-Masfety; Maria E Medina-Mora; Fernando Navarro-Mateu; Akin Ojagbemi; Siobhan O'Neill; Marina Piazza; Jose Posada-Villa; Charlene Rapsey; David R Williams; Miguel Xavier; Yuval Ziv; Ronald C Kessler; Josep M Haro Journal: Psychol Med Date: 2020-04-28 Impact factor: 7.723
Authors: Marit Knapstad; Linn Vathne Lervik; Solbjørg Makalani Myrtveit Sæther; Leif Edvard Aarø; Otto Robert F Smith Journal: Psychother Psychosom Date: 2019-12-03 Impact factor: 17.659
Authors: Joshua Breslau; Carol S North; Melissa L Finucane; Elizabeth Roth; Rebecca L Collins Journal: Psychiatry Date: 2021-07-30 Impact factor: 2.458
Authors: Philip Lindner; Peter Dafgård; Alexander Miloff; Gerhard Andersson; Lena Reuterskiöld; William Hamilton; Per Carlbring Journal: Front Psychiatry Date: 2021-05-20 Impact factor: 4.157
Authors: Stephen X Zhang; Hao Huang; Jizhen Li; Mayra Antonelli-Ponti; Scheila Farias de Paiva; José Aparecido da Silva Journal: Int J Environ Res Public Health Date: 2021-06-30 Impact factor: 3.390